Triamcinolone Hexacetonide
Injection · trading as Hexatrione 2%
Current Active — Day 1836
High impact — Only one manufacturer supplies this drug; any disruption leaves no immediate alternative source.
FDA shortage record
- Substance
- Triamcinolone Hexacetonide
- Brand name
- Hexatrione 2%
- Manufacturers / suppliers
-
- Medexus Pharma, Inc.
- Medexus
- Dosage form
- Injection
- Presentation
- Hexatrione, Injection, 40 mg/2 mL (NDC 59137-570-01)
- Route(s)
- INTRA-ARTICULAR
- Therapeutic category
- Rheumatology
- Package NDC
59137-570-01- Initially posted
- 05/04/2021
- Days on shortage list
- 1836
- Current FDA status
- Current
- Shortage entries (current dataset)
- 1 record for Triamcinolone Hexacetonide
Reason and context
Reason reported: Delay in shipping of the drug
Estimated recovery: TBD
Manufacturer contact
Per the FDA record, the manufacturer's contact for supply inquiries is 1-855-336-3322 Option 9.
If you're affected by this shortage
- Talk to your prescribing clinician or pharmacist about therapeutic alternatives. Do not switch medications on your own.
- Ask your pharmacy to check supply across multiple wholesalers and other branches.
- Check current pharmacy pricing and availability via GoodRx (affiliate link).
- Report a continuing supply problem to FDA via the FDA Drug Shortages contact form.
Sources
- FDA Drug Shortages database, accessed via the openFDA Drug Shortages API.
- FDA Structured Product Label (SPL set ID
bc07ae9f-8a74-6bc8-e053-2995a90afc0d). - FDA UNII identifier:
I7GT1U99Y9. - See the Drug Shortage Tracker methodology for sourcing, update cadence, normalization rules, and limits.
Important
This page reproduces publicly available FDA shortage data for informational purposes only. It is not medical advice and does not establish a clinician-patient relationship. Shortage status changes frequently; verify directly with your pharmacist or the FDA Drug Shortages site before making any treatment decision.